A recently released retrospective study by Montefiore Einstein nephrologists identified comparable patient and organs survival in type 1 and type 2 patients with diabetes after receiving simultaneous kidney and pancreas transplants (SPK). They also found that type 1 diabetics are more likely to develop acute rejection and cytomegalovirus (CMV) viremia as compared to patients with type 2 diabetes.
CMV is a common virus that typically presents no problem to healthy people. It’s most dangerous to newborns, infants and those with weakened immune systems, like transplant patients.
Luz E. Liriano-Ward, MD, Transplant Nephrologist and Associate Professor, Department of Medicine, Montefiore Einstein, and her colleagues at Montefiore Medical Center presented their findings during a poster session at Kidney Week 2022, the world’s premier nephrology meeting held annually by the American Society of Nephrology (ASN).